, Volume 70, Issue 2, pp 675–685 | Cite as

Enhanced IgG1 production by overexpression of nuclear factor kappa B inhibitor zeta (NFKBIZ) in Chinese hamster ovary cells

  • Masayoshi OnitsukaEmail author
  • Yukie Kinoshita
  • Akitoshi Nishizawa
  • Tomomi Tsutsui
  • Takeshi Omasa
Original Article


Several engineering strategies have been employed to improve the production of therapeutic recombinant proteins in Chinese hamster ovary (CHO) cell lines. We have focused on unfolded protein response-based engineering and reported that ATF4 overexpression increases protein production. In this study, transcriptome analysis of ATF4-overexpressed CHO cells was performed using high-coverage expression profiling, to search for another key factor contributing to recombinant protein production. We observed the upregulated expression of transcription factor, nuclear factor (NF)-kappa-B inhibitor zeta (NFKBIZ or Iκbζ), in ATF4-overexpressed cells. A total of 1917 bp of CHO NFKBIZ cDNA was cloned, and two stable cell lines overexpressing NFKBIZ were constructed. We investigated the effects of NFKBIZ on IgG1 production in CHO cells. Although the two stable cell lines, NFKBIZ-A and -B, had the opposite phenotypes in cell growth, the specific IgG1 production rate of both cell lines was enhanced by 1.2–1.4-fold. In the NFKBIZ-A cell line, the synergistic effect between enhanced viable cell density and improved specific IgG1 production rate brought about a large increase in the final IgG1 titer. Luciferase-based NF-κB signaling assay results suggest that altered p50/p50 signaling seems to be due to the opposite phenotypes in cell growth. No difference was observed in the translational levels and intracellular assembly states of IgG1 between mock and two NFKBIZ cell lines, indicating that the secretion machinery of correctly folded IgG1 was enhanced in NFKBIZ-overexpressing cell lines.


High-coverage expression profiling (HiCEP) NF-kappa B inhibitor zeta (NFKBIZ) Antibody production Chinese hamster ovary (CHO) cells 



The authors would like to thank Dr. Tomoshi Ohya (Mitsubishi Tanabe Pharma) for his valuable discussions. This research was partially supported by developing key technologies for discovering and manufacturing pharmaceuticals used for next-generation treatments and diagnoses from the Ministry of Economy, Trade and Industry, Japan (METI) and from the Japan Agency for Medical Research and Development (AMED).

Supplementary material

10616_2017_170_MOESM1_ESM.docx (379 kb)
Supplementary material 1 (DOCX 378 kb)


  1. Barken D, Wang CJ, Kearns J, Cheong R, Hoffmann A, Levchenko A (2005) Comment on “Oscillations in NF-kappaB signaling control the dynamics of gene expression”. Science 308:52 author reply 52 CrossRefGoogle Scholar
  2. Becker E, Florin L, Pfizenmaier K, Kaufmann H (2008) An XBP-1 dependent bottle-neck in production of IgG subtype antibodies in chemically defined serum-free Chinese hamster ovary (CHO) fed-batch processes. J Biotechnol 135:217–223CrossRefGoogle Scholar
  3. Brown AJ, Sweeney B, Mainwaring DO, James DC (2014) Synthetic promoters for CHO cell engineering. Biotechnol Bioeng 111:1638–1647CrossRefGoogle Scholar
  4. Brown AJ, Sweeney B, Mainwaring DO, James DC (2015) NF-kappaB, CRE and YY1 elements are key functional regulators of CMV promoter-driven transient gene expression in CHO cells. Biotechnol J 10:1019–1028CrossRefGoogle Scholar
  5. Cacciatore JJ, Chasin LA, Leonard EF (2010) Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system. Biotechnol Adv 28:673–681CrossRefGoogle Scholar
  6. Datta P, Linhardt RJ, Sharfstein ST (2013) An’omics approach towards CHO cell engineering. Biotechnol Bioeng 110:1255–1271CrossRefGoogle Scholar
  7. Feger F, Dubart A, Lacout C, Dusanter-Fourt I, Mayeux P, Vainchenker W, Dumenil D (1997) Ectopic expression of the erythropoietin receptor in a murine interleukin-6-dependent plasmacytoma cell line (TEPC-2027) confers proliferative responsiveness to erythropoietin. Blood 89:435–445Google Scholar
  8. Fischer S, Handrick R, Otte K (2015) The art of CHO cell engineering: a comprehensive retrospect and future perspectives. Biotechnol Adv 33:1878–1896CrossRefGoogle Scholar
  9. Fukumura R, Takahashi H, Saito T, Tsutsumi Y, Fujimori A, Sato S, Tatsumi K, Araki R, Abe M (2003) A sensitive transcriptome analysis method that can detect unknown transcripts. Nucleic Acids Res 31:e94CrossRefGoogle Scholar
  10. Ghosh G, Wang VY, Huang DB, Fusco A (2012) NF-kappaB regulation: lessons from structures. Immunol Rev 246:36–58CrossRefGoogle Scholar
  11. Haredy AM, Nishizawa A, Honda K, Ohya T, Ohtake H, Omasa T (2013) Improved antibody production in Chinese hamster ovary cells by ATF4 overexpression. Cytotechnology 65:993–1002CrossRefGoogle Scholar
  12. Hasegawa H, Wendling J, He F, Trilisky E, Stevenson R, Franey H, Kinderman F, Li G, Piedmonte DM, Osslund T, Shen M, Ketchem RR (2011) In vivo crystallization of human IgG in the endoplasmic reticulum of engineered Chinese hamster ovary (CHO) cells. J Biol Chem 286:19917–19931CrossRefGoogle Scholar
  13. Hussain H, Maldonado-Agurto R, Dickson AJ (2014) The endoplasmic reticulum and unfolded protein response in the control of mammalian recombinant protein production. Biotechnol Lett 36:1581–1593CrossRefGoogle Scholar
  14. Khan SU, Schroder M (2008) Engineering of chaperone systems and of the unfolded protein response. Cytotechnology 57:207–231CrossRefGoogle Scholar
  15. Kildegaard HF, Baycin-Hizal D, Lewis NE, Betenbaugh MJ (2013) The emerging CHO systems biology era: harnessing the ‘omics revolution for biotechnology. Curr Opin Biotechnol 24:1102–1107CrossRefGoogle Scholar
  16. Li F, Vijayasankaran N, Shen AY, Kiss R, Amanullah A (2010) Cell culture processes for monoclonal antibody production. MAbs 2:466–479CrossRefGoogle Scholar
  17. Ma Y, Hendershot LM (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4:966–977CrossRefGoogle Scholar
  18. Makishima F, Terada S, Mikami T, Suzuki E (1992) Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivity. Cytotechnology 10:15–23CrossRefGoogle Scholar
  19. Motoyama M, Yamazaki S, Eto-Kimura A, Takeshige K, Muta T (2005) Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein. J Biol Chem 280:7444–7451CrossRefGoogle Scholar
  20. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, Unitt JF, Sullivan E, Grimley R, Benson N, Broomhead D, Kell DB, White MR (2004) Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 306:704–708CrossRefGoogle Scholar
  21. Ohya T, Hayashi T, Kiyama E, Nishii H, Miki H, Kobayashi K, Honda K, Omasa T, Ohtake H (2008) Improved production of recombinant human antithrombin III in Chinese hamster ovary cells by ATF4 overexpression. Biotechnol Bioeng 100:317–324CrossRefGoogle Scholar
  22. Omasa T, Higashiyama K, Shioya S, Suga K (1992) Effects of lactate concentration on hybridoma culture in lactate-controlled fed-batch operation. Biotechnol Bioeng 39:556–564CrossRefGoogle Scholar
  23. Omasa T, Takami T, Ohya T, Kiyama E, Hayashi T, Nishii H, Miki H, Kobayashi K, Honda K, Ohtake H (2008) Overexpression of GADD34 enhances production of recombinant human antithrombin III in Chinese hamster ovary cells. J Biosci Bioeng 106:568–573CrossRefGoogle Scholar
  24. Omasa T, Onitsuka M, Kim WD (2010) Cell engineering and cultivation of chinese hamster ovary (CHO) cells. Curr Pharm Biotechnol 11:233–240CrossRefGoogle Scholar
  25. Onitsuka M, Omasa T (2015) Rapid evaluation of N-glycosylation status of antibodies with chemiluminescent lectin-binding assay. J Biosci Bioeng 120:107–110CrossRefGoogle Scholar
  26. Pahl HL, Baeuerle PA (1997) The ER-overload response: activation of NF-kappa B. Trends Biochem Sci 22:63–67CrossRefGoogle Scholar
  27. Pybus LP, Dean G, West NR, Smith A, Daramola O, Field R, Wilkinson SJ, James DC (2014) Model-directed engineering of “difficult-to-express” monoclonal antibody production by Chinese hamster ovary cells. Biotechnol Bioeng 111:372–385CrossRefGoogle Scholar
  28. Takagi Y, Yamazaki T, Masuda K, Nishii S, Kawakami B, Omasa T (2017) Identification of regulatory motifs in the CHO genome for stable monoclonal antibody production. Cytotechnology 69:451–460. CrossRefGoogle Scholar
  29. Tigges M, Fussenegger M (2006) Xbp1-based engineering of secretory capacity enhances the productivity of Chinese hamster ovary cells. Metab Eng 8:264–272CrossRefGoogle Scholar
  30. Totzke G, Essmann F, Pohlmann S, Lindenblatt C, Janicke RU, Schulze-Osthoff K (2006) A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. J Biol Chem 281:12645–12654CrossRefGoogle Scholar
  31. Van Snick J (1990) Interleukin-6: an overview. Annu Rev Immunol 8:253–278CrossRefGoogle Scholar
  32. Wietek C, O’Neill LA (2007) Diversity and regulation in the NF-kappaB system. Trends Biochem Sci 32:311–319CrossRefGoogle Scholar
  33. Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393–1398CrossRefGoogle Scholar
  34. Yamamoto M, Yamazaki S, Uematsu S, Sato S, Hemmi H, Hoshino K, Kaisho T, Kuwata H, Takeuchi O, Takeshige K, Saitoh T, Yamaoka S, Yamamoto N, Yamamoto S, Muta T, Takeda K, Akira S (2004) Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430:218–222CrossRefGoogle Scholar
  35. Yamazaki S, Muta T, Matsuo S, Takeshige K (2005) Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization. J Biol Chem 280:1678–1687CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2017

Authors and Affiliations

  1. 1.Graduate School of Technology, Industrial and Social SciencesTokushima UniversityTokushimaJapan
  2. 2.Institute of Technology and Science, Tokushima UniversityTokushimaJapan
  3. 3.Graduate School of EngineeringOsaka UniversitySuitaJapan

Personalised recommendations